Management of Individuals with Diabetes at High Risk for Hypoglycemia

Publication Date: December 7, 2022
Last Updated: April 19, 2023

Recommendations

Recommendation 1

Endocrine Society (ES) recommends CGM rather than self-monitoring of blood glucose (SMBG) by fingerstick for patients with T1D receiving multiple daily injections (MDIs). (Moderate, 1 – Strong recommendation for or against)
Remarks:
  • Comprehensive patient education on how to use and troubleshoot CGM devices and interpret these data is critically important for maximum benefit and successful outcomes.
  • SMBG continues to be necessary to validate or confirm CGM values; e.g., when symptoms do not match sensor glucose values and during the sensor warm-up period. Therefore, patients using CGM must continue to have access to SMBG.
1846524

Video

Overview

Title

Management of Individuals with Diabetes at High Risk for Hypoglycemia

Authoring Organization